Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer
Abstract
:1. Introduction
2. Methods
2.1. Overview of the Trial
2.2. Translation Process
2.3. Study Instruments
2.3.1. Demographic and Clinical Characteristics Data
2.3.2. Dyspnoea-12 Questionnaire (D-12)
2.3.3. Borg CR-10 Scale
2.3.4. Numerical Rating Scale (NRS)
2.3.5. Hospital Anxiety and Depression Scale (HADS)
2.3.6. Saint George’s Respiratory Questionnaire (SGRQ)
2.4. Acceptability and Psychometric Assessment
2.4.1. Acceptability and Floor and Ceiling Effects
2.4.2. Reliability
2.4.3. Validity
2.4.4. Discriminating Performance and Invariance
2.5. Statistical Analysis
3. Results
3.1. Sample Characteristics
3.2. Acceptability and Floor and Ceiling Effects
3.3. Reliability of the D-12
3.4. Convergent Validity of the D-12
3.5. Discriminating Performance and Invariance of the D-12
4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
D-12 | Dyspnoea-12 Questionnaire |
NRS | Numerical Rating Scale |
HADS | Hospital Anxiety and Depression Scale |
SGRQ | Saint George’s Respiratory Questionnaire |
6-MWTD | 6-minute Walk Test Distance |
MRC | Medical Research Council |
CDS | Cancer Dyspnoea Scale |
CRQ | Chronic Respiratory Questionnaire |
COPD | Chronic Obstructive Pulmonary Disease |
RCT | Randomised Controlled Trial |
QoL | Quality of Life |
References
- Parshall, M.B.; Schwartzstein, R.M.; Adams, L.; Banzett, R.B.; Manning, H.L.; Bourbeau, J.; Calverley, P.M.; Gift, A.G.; Harver, A.; Lareau, S.C.; et al. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am. J. Respir. Crit. Care Med. 2012, 185, 435–452. [Google Scholar] [CrossRef] [PubMed]
- Julià-Torras, J.; Almeida Felipe, J.; Gándara del Castillo, Á.; González-Barboteo, J.; Forero, D.; Alegre, S.; Cuervo-Pinna, M.Á.; Serna, J.; Muñoz-Unceta, N.; Alonso-Babarro, A. Prevalence, Clinical Characteristics, and Management of Episodic Dyspnea in Advanced Lung Cancer Outpatients: A Multicenter Nationwide Study—The INSPIRA-DOS Study. J. Palliat. Med. 2022, 25, 1197–1207. [Google Scholar] [CrossRef] [PubMed]
- Sung, J.H.; Brown, M.C.; Perez-Cosio, A.; Pratt, L.; Houad, J.; Liang, M.; Gill, G.; Moradian, S.; Liu, G.; Howell, D. Acceptability and accuracy of patient-reported outcome measures (PROMs) for surveillance of breathlessness in routine lung cancer care: A mixed-method study. Lung Cancer 2020, 147, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Kathiresan, G.; Clement, R.F.; Sankaranarayanan, M.T. Dyspnea in lung cancer patients: A systematic review. Lung Cancer Targets Ther. 2010, 1, 141–150. [Google Scholar] [CrossRef] [PubMed]
- Ruano-Raviña, A.; Provencio, M.; de Juan, V.C.; Carcereny, E.; Moran, T.; Rodriguez-Abreu, D.; López-Castro, R.; Albite, E.C.; Guirado, M.; González, L.G.; et al. Lung cancer symptoms at diagnosis: Results of a nationwide registry study. ESMO Open 2020, 5, e001021. [Google Scholar] [CrossRef] [PubMed]
- Bade, B.C.; Brooks, M.C.; Nietert, S.B.; Ulmer, A.; Thomas, D.D.; Nietert, P.J.; Scott, J.B.; Silvestri, G.A. Assessing the correlation between physical activity and quality of life in advanced lung cancer. Integr. Cancer Ther. 2018, 17, 73–79. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.; Qian, X.; Tang, X.; Shen, C.; Zhou, Y.; Pan, X.; Li, Y. The links between symptom burden, illness perception, psychological resilience, social support, coping modes, and cancer-related worry in Chinese early-stage lung cancer patients after surgery: A cross-sectional study. BMC Psychol. 2024, 12, 463. [Google Scholar] [CrossRef]
- Lucas-Ruano, D.; Sanchez-Gomez, C.; Rihuete-Galve, M.I.; Garcia-Martin, A.; Fonseca-Sanchez, E.; Fernández-Rodríguez, E.J. Descriptive Study on the Relationship between Dyspnea, Physical Performance, and Functionality in Oncology Patients. Healthcare 2024, 12, 1675. [Google Scholar] [CrossRef]
- Johnson, M.J.; Currow, D.C.; Booth, S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev. Respir. Med. 2014, 8, 151–161. [Google Scholar] [CrossRef]
- Ruparel, M.; Quaife, S.L.; Dickson, J.L.; Horst, C.; Tisi, S.; Hall, H.; Taylor, M.N.; Ahmed, A.; Shaw, P.J.; Burke, S.; et al. Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort. Ann. Am. Thorac. Soc. 2020, 17, 869–878. [Google Scholar] [CrossRef] [PubMed]
- Borg, G. A category scale with ratio properties for intermodal and interindividual comparisons. Psychophys. Judgm. Process Percept. 1982, 25–34. [Google Scholar]
- Grant, S.; Aitchison, T.; Henderson, E.; Christie, J.; Zare, S.; Mc Murray, J.; Dargie, H. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 1999, 116, 1208–1217. [Google Scholar] [CrossRef] [PubMed]
- Gift, A.G.; Narsavage, G. Validity of the numeric rating scale as a measure of dyspnea. Am. J. Crit. Care 1998, 7, 200–204. [Google Scholar] [CrossRef] [PubMed]
- Bestall, J.C.; Paul, E.A.; Garrod, R.; Garnham, R.; Jones, P.W.; Wedzicha, J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54, 581–586. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, K.; Akechi, T.; Okuyama, T.; Nishiwaki, Y.; Uchitomi, Y. Development and validation of the Cancer Dyspnoea Scale: A multidimensional, brief, self-rating scale. Br. J. Cancer 2000, 82, 800–805. [Google Scholar] [CrossRef]
- Sunjaya, A.; Poulos, L.; Reddel, H.; Jenkins, C. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir. Med. 2022, 203, 106984. [Google Scholar] [CrossRef] [PubMed]
- Wijkstra, P.J.; TenVergert, E.M.; Van Altena, R.; Otten, V.; Postma, D.S.; Kraan, J.; Koeter, G.H. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994, 49, 465–467. [Google Scholar] [CrossRef] [PubMed]
- Meguro, M.; Barley, E.A.; Spencer, S.; Jones, P.W. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 2007, 132, 456–463. [Google Scholar] [CrossRef]
- Elliott-Button, H.L.; Johnson, M.J.; Nwulu, U.; Clark, J. Identification and assessment of breathlessness in clinical practice: A systematic review and narrative synthesis. J. Pain Symptom Manag. 2020, 59, 724–733. [Google Scholar] [CrossRef] [PubMed]
- Lewthwaite, H.; Jensen, D.; Ekström, M. How to assess breathlessness in chronic obstructive pulmonary disease. Int. J. Chronic Obstr. Pulm. Dis. 2021, 16, 1581–1598. [Google Scholar] [CrossRef]
- Yorke, J.; Moosavi, S.H.; Shuldham, C.; Jones, P.W. Quantification of dyspnoea using descriptors: Development and initial testing of the Dyspnoea-12. Thorax 2010, 65, 21–26. [Google Scholar] [CrossRef] [PubMed]
- Banzett, R.B.; Moosavi, S.H. Measuring dyspnoea: New multidimensional instruments to match our 21st century understanding. Eur. Respir. J. 2017, 49, 1602473. [Google Scholar] [CrossRef] [PubMed]
- Yorke, J.; Russell, A.-M.; Swigris, J.; Shuldham, C.; Haigh, C.; Rochnia, N.; Hoyle, J.; Jones, P.W. Assessment of dyspnea in asthma: Validation of The Dyspnea-12. J. Asthma 2011, 48, 602–608. [Google Scholar] [CrossRef] [PubMed]
- Yorke, J.; Swigris, J.; Russell, A.-M.; Moosavi, S.H.; Kwong, G.N.M.; Longshaw, M.; Jones, P.W. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011, 139, 159–164. [Google Scholar] [CrossRef]
- Yorke, J.; Armstrong, I.; Jaarsma, T.; Deaton, C.; Fitzsimmons, D.; Fridlund, B.; Hardig, B.M.; Mahrer-Imhof, R.; Moons, P.; Noureddine, S.; et al. The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12. Eur. J. Cardiovasc. Nurs. 2014, 13, 506–514. [Google Scholar] [CrossRef] [PubMed]
- Tan, J.-Y.; Yorke, J.; Harle, A.; Smith, J.; Blackhall, F.; Pilling, M.; Molassiotis, A. Assessment of breathlessness in lung cancer: Psychometric properties of the Dyspnea-12 questionnaire. J. Pain Symptom Manag. 2017, 53, 208–215. [Google Scholar] [CrossRef]
- Al-Gamal, E.; Yorke, J.; Al-Shwaiyat, M.K. Dyspnea-12-Arabic: Testing of an instrument to measure breathlessness in Arabic patients with chronic obstructive pulmonary disease. Heart Lung 2014, 43, 244–248. [Google Scholar] [CrossRef]
- Beaumont, M.; Couturaud, F.; Jego, F.; Pichon, R.; Le Ber, C.; Péran, L.; Roge, C.; Renault, D.; Narayan, S.; Reychler, G. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire. Int. J. Chronic Obstr. Pulm. Dis. 2018, 13, 1399. [Google Scholar] [CrossRef]
- Lee, B.Y.; Lee, S.; Lee, J.S.; Song, J.W.; Lee, S.-D.; Jang, S.H.; Jung, K.-S.; Hwang, Y.I.; Oh, Y.-M. Validity and reliability of CAT and Dyspnea-12 in bronchiectasis and tuberculous destroyed lung. Tuberc. Respir. Dis. 2012, 72, 467–474. [Google Scholar] [CrossRef]
- Kako, J.; Kobayashi, M.; Kajiwara, K.; Kimura, Y.; Oosono, Y.; Takegata, M.; Nakano, K.; Matsuda, Y.; Nakamura, N.; Kawashima, N.; et al. Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer. J. Pain Symptom Manag. 2022, 64, e83–e89. [Google Scholar] [CrossRef] [PubMed]
- Caruso, R.; Arrigoni, C.; Groppelli, K.; Magon, A.; Dellafiore, F.; Pittella, F.; Grugnetti, A.M.; Chessa, M.; Yorke, J. Italian version of Dyspnoea-12: Cultural-linguistic validation, quantitative and qualitative content validity study. Acta Bio Medica Atenei Parm. 2017, 88, 426–434. [Google Scholar]
- Simsic, A.A.; Yorke, J.; Regueiro, E.G.; Di Lorenzo, V.P.; Baddini-Martinez, J. Validation of the dyspnoea-12 scale into Portuguese speaking COPD patients. Clin. Respir. J. 2018, 12, 1942–1948. [Google Scholar] [CrossRef] [PubMed]
- Garratt, A.M.; Nerheim, E.M.; Einvik, G.; Stavem, K.; Edvardsen, A. Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD. BMJ Open Respir. Res. 2022, 9, e001262. [Google Scholar] [CrossRef]
- Sundh, J.; Ekström, M. Dyspnoea-12: A translation and linguistic validation study in a Swedish setting. BMJ Open 2017, 7, e014490. [Google Scholar] [CrossRef] [PubMed]
- Choi, T.C.M.; Chan, L.L.Y.; Tsang, H.C.; Vong, Y.P.; Cheng, Y.K.; To, Y.L.; Choo, K.L.; Yorke, J. Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease. Clin. Respir. J. 2021, 15, 1081–1087. [Google Scholar] [CrossRef]
- Yang, R.; Wang, W.S.Y. Categorical perception of Chinese characters by simplified and traditional Chinese readers. Read. Writ. 2018, 31, 1133–1154. [Google Scholar] [CrossRef]
- Molassiotis, A.; Charalambous, A.; Taylor, P.; Stamataki, Z.; Summers, Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: A feasibility randomised trial. Support. Care Cancer 2015, 23, 1637–1645. [Google Scholar] [CrossRef]
- Hall, D.A.; Zaragoza Domingo, S.; Hamdache, L.Z.; Manchaiah, V.; Thammaiah, S.; Evans, C.; Wong, L.L.N.; On behalf of the International Collegium of Rehabilitative Audiology and TINnitus Research NETwork. A good practice guide for translating and adapting hearing-related questionnaires for different languages and cultures. Int. J. Audiol. 2018, 57, 161–175. [Google Scholar] [CrossRef] [PubMed]
- Koller, M.; Kantzer, V.; Mear, I.; Zarzar, K.; Martin, M.; Greimel, E.; Bottomley, A.; Arnott, M.; Kuliś, D.; Tca-Sig, T.I. The process of reconciliation: Evaluation of guidelines for translating quality-of-life questionnaires. Expert Rev. Pharmacoecon. Outcomes Res. 2012, 12, 189–197. [Google Scholar] [CrossRef]
- Burdon, J.G.; Juniper, E.F.; Killian, K.J.; Hargreave, F.E.; Campbell, E.J. The perception of breathlessness in asthma. Am. Rev. Respir. Dis. 1982, 126, 825–828. [Google Scholar] [PubMed]
- Mahlen, D.A. The measurement of dyspnea during exercise in patients with lung disease. Chest 1992, 101, 242S–247S. [Google Scholar] [CrossRef]
- Fierro-Carrion, G.; Mahler, D.A.; Ward, J.; Baird, J.C. Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest 2004, 125, 77–84. [Google Scholar] [CrossRef] [PubMed]
- Snaith, R.P. The hospital anxiety and depression scale. Health Qual. Life Outcomes 2003, 1, 29. [Google Scholar] [CrossRef] [PubMed]
- Walker, J.; Postma, K.; McHugh, G.S.; Rush, R.; Coyle, B.; Strong, V.; Sharpe, M. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J. Psychosom. Res. 2007, 63, 83–91. [Google Scholar] [CrossRef] [PubMed]
- Annunziata, M.A.; Muzzatti, B.; Bidoli, E.; Flaiban, C.; Bomben, F.; Piccinin, M.; Gipponi, K.M.; Mariutti, G.; Busato, S.; Mella, S. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support. Care Cancer 2020, 28, 3921–3926. [Google Scholar] [CrossRef]
- Jones, P.; Quirk, F.; Baveystock, C. The St George’s Respiratory Questionnaire. Respir. Med. 1991, 85, 25–31. [Google Scholar] [CrossRef]
- Xu, W.; Collet, J.-P.; Shapiro, S.; Lin, Y.; Yang, T.; Wang, C.; Bourbeau, J. Validation and clinical interpretation of the St George’s Respiratory Questionnaire among COPD patients, China. Int. J. Tuberc. Lung Dis. 2009, 13, 181–189. [Google Scholar] [PubMed]
- Terwee, C.B.; Bot, S.D.M.; de Boer, M.R.; van der Windt, D.A.; Knol, D.L.; Dekker, J.; Bouter, L.M.; de Vet, H.C.W. Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 2007, 60, 34–42. [Google Scholar] [CrossRef] [PubMed]
- Henson, R.K. Understanding internal consistency reliability estimates: A conceptual primer on coefficient alpha. Meas. Eval. Couns. Dev. 2001, 34, 177–189. [Google Scholar] [CrossRef]
- DeVellis, R.F.; Thorpe, C.T. Scale Development: Theory and Applications; Sage Publications: Thousand Oaks, CA, USA, 2021. [Google Scholar]
- Streiner, D.L.; Norman, G.R.; Cairney, J. Health Measurement Scales: A Practical Guide to Their Development and Use; Oxford University Press: New York, NY, USA, 2015. [Google Scholar]
- Cunningham, W.A.; Preacher, K.J.; Banaji, M.R. Implicit attitude measures: Consistency, stability, and convergent validity. Psychol. Sci. 2001, 12, 163–170. [Google Scholar] [CrossRef] [PubMed]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences; Academic Press: New York, NY, USA, 2013. [Google Scholar]
- Tsao, M.; Barnes, E.; Chow, E. The relationship between dyspnea and blood oxygen saturation. J. Pain Manag. 2019, 12, 109–114. [Google Scholar]
- Waatevik, M.; Johannessen, A.; Hardie, J.A.; Bjordal, J.M.; Aukrust, P.; Bakke, P.S.; Eagan, T.M. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD J. Chronic Obstr. Pulm. Dis. 2012, 9, 227–234. [Google Scholar] [CrossRef] [PubMed]
- Ghalehbandi, M.; Aloosh, O.; Rahimi-Golkhandan, A.; Abounoori, M.; Aloosh, A.; Afshar, H.; Khosravifar, S. The association between sleep quality, health status and disability due to breathlessness in chronic obstructive pulmonary disease patients. Clin. Respir. J. 2021, 15, 1168–1174. [Google Scholar] [CrossRef]
- Dudgeon, D.J.; Kristjanson, L.; Sloan, J.A.; Lertzman, M.; Clement, K. Dyspnea in cancer patients: Prevalence and associated factors. J. Pain Symptom Manag. 2001, 21, 95–102. [Google Scholar] [CrossRef]
- Ekström, M.; Johnson, M.; Schiöler, L.; Kaasa, S.; Hjermstad, M.; Currow, D. Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study. Support. Care Cancer 2016, 24, 3803–3811. [Google Scholar] [CrossRef]
- Tabak, C.; Smit, H.A.; Heederik, D.; Ocke, M.C.; Kromhout, D. Diet and chronic obstructive pulmonary disease: Independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin. Exp. Allergy 2001, 31, 747–755. [Google Scholar] [CrossRef] [PubMed]
- Tavakol, M.; Dennick, R. Making sense of Cronbach’s alpha. Int. J. Med. Educ. 2011, 2, 53. [Google Scholar] [CrossRef]
- Gupta, D.; Lis, C.G.; Grutsch, J.F. The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer. Support. Care Cancer 2007, 15, 533–538. [Google Scholar] [CrossRef]
- Damani, A.; Ghoshal, A.; Salins, N.; Deodhar, J.; Muckaden, M. Prevalence and intensity of dyspnea in advanced cancer and its impact on quality of life. Indian J. Palliat. Care 2018, 24, 44–50. [Google Scholar]
- Schunk, F.; Trommsdorff, G.; König-Teshnizi, D. Regulation of positive and negative emotions across cultures: Does culture moderate associations between emotion regulation and mental health? Cogn. Emot. 2022, 36, 352–363. [Google Scholar] [CrossRef]
- Tu, J.; Shen, M.; Li, Z. When cultural values meets professional values: A qualitative study of chinese nurses’ attitudes and experiences concerning death. BMC Palliat. Care 2022, 21, 181. [Google Scholar]
- Knekta, E.; Runyon, C.; Eddy, S. One size doesn’t fit all: Using factor analysis to gather validity evidence when using surveys in your research. CBE—Life Sci. Educ. 2019, 18, rm1. [Google Scholar] [CrossRef]
Demographic and Clinical Information | Number (%) | |
---|---|---|
Educational background (n = 196) | No formal education/uneducated | 20 (10.2) |
Primary school | 50 (25.5) | |
Secondary school | 71 (36.2) | |
High school or vocational school | 21 (10.7) | |
College diploma | 18 (9.2) | |
University degree or above | 16 (8.2) | |
Marital status (n = 196) | Single | 2 (1.0) |
Married | 194 (99.0) | |
Gender (n = 196) | Male | 91 (46.4) |
Female | 105 (53.6) | |
Occupation (n = 194) | Professional and technical personnel | 16 (8.2) |
Manual worker | 49 (25.0) | |
Clerical or administrative worker | 10 (5.1) | |
No longer working * | 77 (39.3) | |
Other | 42 (21.4) | |
Household income (RMB/month) (n = 178) | <3000 | 106 (54.1) |
3000–6000 | 61 (31.1) | |
6001–10,000 | 10 (5.1) | |
>10,000 | 1 (0.5) | |
Source of healthcare insurance (n = 195) | NCMS | 88 (44.9) |
URBMI and UEBMI | 104 (53.1) | |
Self-paid | 3 (1.5) | |
BMI (n = 194) | Underweight (<18.5) | 12 (6.1) |
Normal or healthy weight (18.5–22.9) | 85 (43.4) | |
Overweight (23–24.9) | 46 (23.5) | |
Obese (≥25) | 53 (27) | |
Cancer stage (n = 183) | I | 124 (63.3) |
IIA | 8 (4.1) | |
IIB | 10 (5.1) | |
IIIA | 15 (7.7) | |
IIIB | 8 (4.1) | |
IIIC | 1 (0.5) | |
IV | 17 (8.7) | |
Surgery types (n = 169) | Left upper lobectomy | 46 (23.5) |
Left lower lobectomy | 12 (6.1) | |
Right upper lobectomy | 51 (26.0) | |
Right lower lobectomy | 33 (16.8) | |
Microwave ablation | 1 (0.5) | |
Other | 26 (13.3) | |
Hypertension (n = 195) | Yes | 45 (23.0) |
No | 150 (76.5) | |
Exercise (Hour/week) (n = 195) | 0–2 | 157 (80.1) |
3–4 | 25 (12.8) | |
5–6 | 9 (4.6) | |
>6 | 4 (2.0) | |
Smoking (n = 195) | Never smoked | 129 (65.8) |
Current smoking | 3 (1.5) | |
Previous smoking | 63 (32.1) | |
Alcohol consumption (n = 196) | Yes | 71 (36.2) |
No | 125 (63.8) | |
Insomnia (n = 196) | Yes | 72 (36.7) |
No | 124 (63.3) | |
Diabetes (n = 196) | Yes | 15 (7.7) |
No | 181 (93.2) | |
Asthma (n = 196) | Yes | 4 (2.0) |
No | 192 (98.0) | |
Pneumonectasis (n = 196) | Yes | 8 (4.1) |
No | 188 (95.9) | |
Pulmonary tuberculosis (n = 196) | Yes | 6 (3.1) |
No | 190 (96.9) | |
Heart diseases (n = 194) | Yes | 12 (6.1) |
No | 182 (92.9) |
No. of Subjects Who Responded to the Item | No. of Subjects Who Did Not Respond to the Item | Missing Value (%) | Floor Effect (%) | Ceiling Effect (%) | |
---|---|---|---|---|---|
D-12 item 1 | 195 | 1 | 0.5% | 17.4% | 1.0% |
D-12 item 2 | 195 | 1 | 0.5% | 25.5% | 0.5% |
D-12 item 3 | 195 | 1 | 0.5% | 8.2% | 2.6% |
D-12 item 4 | 195 | 1 | 0.5% | 12.8% | 2.0% |
D-12 item 5 | 195 | 1 | 0.5% | 25.0% | 0.5% |
D-12 item 6 | 195 | 1 | 0.5% | 17.3% | 0.5% |
D-12 item 7 | 195 | 1 | 0.5% | 77.0% | 0.5% |
D-12 item 8 | 195 | 1 | 0.5% | 91.8% | 0% |
D-12 item 9 | 194 | 2 | 1.0% | 91.3% | 0% |
D-12 item 10 | 193 | 3 | 1.5% | 91.3% | 0% |
D-12 item 11 | 195 | 1 | 0.5% | 82.7% | 0% |
D-12 item 12 | 195 | 1 | 0.5% | 81.6% | 0% |
D-12 Physical | 195 | 1 | 0.5% | 0% | 0.5% |
D-12 Emotional | 192 | 4 | 2.0% | 79.1% | 0% |
No. of subjects who responded to all the items | No. of subjects who did not respond to one or more of the items | ||||
D-12 total | 192 | 4 | 2.0% | 0% | 0% |
Question Number and Content | n | Mean Score | SD | Corrected Item–Total Correlation | Cronbach’s Alpha if Item Deleted | |
---|---|---|---|---|---|---|
Item 1 | My breath does not go in all the way | 195 | 1.1 | 0.7 | 0.47 | 0.82 |
Item 2 | My breathing requires more work | 195 | 0.9 | 0.7 | 0.47 | 0.82 |
Item 3 | I feel short of breath | 195 | 1.4 | 0.7 | 0.30 | 0.83 |
Item 4 | I have difficulty catching my breath | 195 | 1.3 | 0.7 | 0.40 | 0.83 |
Item 5 | I cannot get enough air | 195 | 1.0 | 0.7 | 0.49 | 0.81 |
Item 6 | My breathing is uncomfortable | 195 | 1.0 | 0.6 | 0.45 | 0.82 |
Item 7 | My breathing is exhausting | 195 | 0.3 | 0.5 | 0.65 | 0.80 |
Item 8 | My breathing makes me feel depressed | 195 | 0.1 | 0.3 | 0.57 | 0.82 |
Item 9 | My breathing makes me feel miserable | 194 | 0.1 | 0.3 | 0.64 | 0.81 |
Item 10 | My breathing is distressing | 193 | 0.1 | 0.3 | 0.66 | 0.81 |
Item 11 | My breathing makes me agitated | 195 | 0.2 | 0.4 | 0.60 | 0.81 |
Item 12 | My breathing is irritating | 195 | 0.2 | 0.5 | 0.63 | 0.81 |
D-12 Physical | 195 | 7.0 | 2.8 | |||
D-12 Emotional | 192 | 0.7 | 1.6 | |||
D-12 Total score | 192 | 7.7 | 3.9 |
Questionnaire/Subscale | n | Mean Score | SD |
---|---|---|---|
Borg score | 195 | 4.2 | 1.5 |
NRS1 | 195 | 4.5 | 2.1 |
NRS2 | 195 | 2.5 | 1.3 |
SGRQ Symptom | 196 | 24.0 | 14.4 |
SGRQ Activity | 196 | 44.6 | 16.0 |
SGRQ Impact | 196 | 19.9 | 13.6 |
SGRQ Total | 196 | 28.2 | 13.1 |
HADS-A | 195 | 3.1 | 2.7 |
HADS-D | 191 | 1.8 | 2.5 |
HADS total | 191 | 4.9 | 4.8 |
D-12 Total Score | D-12 Physical | D-12 Emotional | Borg | NRS1 | NRS2 | SGRQ Symptom | SGRQ Activity | SGRQ Impact | SGRQ Total | HADS-A | HADS-D | HADS Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D-12 total score | 1.000 | ||||||||||||
D-12 Physical | 0.955 ** | 1.000 | |||||||||||
D-12 Emotional | 0.554 ** | 0.340 ** | 1.000 | ||||||||||
Borg | 0.456 ** | 0.533 ** | 0.075 | 1.000 | |||||||||
NRS1 | 0.457 ** | 0.547 ** | −0.023 | 0.726 ** | 1.000 | ||||||||
NRS2 | 0.434 ** | 0.505 ** | 0.100 | 0.703 ** | 0.827 ** | 1.000 | |||||||
SGRQ Symptom | 0.352 ** | 0.422 ** | −0.003 | 0.407 ** | 0.571 ** | 0.437 ** | 1.000 | ||||||
SGRQ Activity | 0.584 ** | 0.584 ** | 0.308 ** | 0.487 ** | 0.502 ** | 0.530 ** | 0.480 ** | 1.000 | |||||
SGRQ Impact | 0.553 ** | 0.573 ** | 0.302 ** | 0.511 ** | 0.547 ** | 0.583 ** | 0.577 ** | 0.690 ** | 1.000 | ||||
SGRQ Total | 0.599 ** | 0.621 ** | 0.283 ** | 0.542 ** | 0.606 ** | 0.607 ** | 0.713 ** | 0.841 ** | 0.940 ** | 1.000 | |||
HADS-A | 0.415 ** | 0.343 ** | 0.443 ** | 0.242 ** | 0.233 ** | 0.321 ** | 0.205 ** | 0.297 ** | 0.460 ** | 0.421 ** | 1.000 | ||
HADS-D | 0.409 ** | 0.301 ** | 0.502 ** | −0.064 | −0.050 | 0.096 | −0.084 | 0.188 ** | 0.279 ** | 0.211 ** | 0.517 ** | 1.000 | |
HADS total | 0.461 ** | 0.361 ** | 0.524 ** | 0.128 | 0.131 | 0.262 ** | 0.100 | 0.287 ** | 0.442 ** | 0.381 ** | 0.908 ** | 0.810 ** | 1.000 |
Demographic and Clinical Group | D-12 Total Score Mean Rank | D-12 Total Score Mean, SD | Z/Kruskal–Wallis H | p-Value | |
---|---|---|---|---|---|
Insomnia | Yes (n = 70) | 121.4 | 9.4 (4.7) | −4.47 | <0.01 |
No (n = 122) | 82.2 | 6.6 (2.8) | |||
Use of alcohol | Yes (n = 69) | 84.1 | 6.5 (2.4) | −2.34 | 0.019 |
No (n = 123) | 103.5 | 8.3 (4.4) | |||
Cancer stage | I (n = 121) | 85.2 | 7.1 (2.9) | 22.99 | <0.01 |
IIA (n = 8) | 50.5 | 5.3 (2.7) | |||
IIIB (n = 10) | 94.3 | 7.4 (2.6) | |||
IIIA (n = 15) | 141.0 | 12.1 (5.5) | |||
IIIB (n = 8) | 91.8 | 7.4 (2.9) | |||
IIIC (n = 1) | 171.5 | - | |||
IV (n = 17) | 95.1 | 9.3 (6.7) | |||
Surgery type | Left upper lobectomy (n = 46) | 90.7 | 7.6 (2.8) | 13.16 | 0.033 |
Left lower lobectomy (n = 12) | 90.8 | 7.4 (2.5) | |||
Right upper lobectomy (n = 50) | 74.7 | 6.6 (2.8) | |||
Right lower lobectomy (n = 32) | 99.3 | 9.1 (5.1) | |||
Microwave ablation (n = 1) | 5.0 | - | |||
Other (n = 25) | 67.3 | 6.6 (3.5) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Liu, X.; Peng, B.; Wang, T.; Molassiotis, A.; Yorke, J.; Yao, L.; Zheng, S.; Tan, J.-Y.; Huang, H. Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer. Healthcare 2025, 13, 201. https://doi.org/10.3390/healthcare13020201
Liu X, Peng B, Wang T, Molassiotis A, Yorke J, Yao L, Zheng S, Tan J-Y, Huang H. Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer. Healthcare. 2025; 13(2):201. https://doi.org/10.3390/healthcare13020201
Chicago/Turabian StyleLiu, Xianliang, Bo Peng, Tao Wang, Alex Molassiotis, Janelle Yorke, Liqun Yao, Silin Zheng, Jing-Yu (Benjamin) Tan, and Houqiang Huang. 2025. "Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer" Healthcare 13, no. 2: 201. https://doi.org/10.3390/healthcare13020201
APA StyleLiu, X., Peng, B., Wang, T., Molassiotis, A., Yorke, J., Yao, L., Zheng, S., Tan, J.-Y., & Huang, H. (2025). Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer. Healthcare, 13(2), 201. https://doi.org/10.3390/healthcare13020201